RxDoctor Payments Data

Robin Franz, MD

Family Medicine · Canal Winchester, OHNPI 1285748806

Payments from drug & device makers

$4,467in general payments, 2019–2025

Across 288 payments — averaging $15.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$468
  • Novo Nordisk$445
  • AbbVie$424
  • Lilly USA, LLC$359
  • Amgen$273
  • Amarin Pharma, Inc.$201
  • plus $2K from 44 others

What the payments were for

  • Food & beverage$4,455100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,467 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$100,630
Medicare patients
207
Services billed
2,984

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin95$134,650
TrulicityDulaglutide62$88,094
EliquisApixaban73$78,975
JanuviaSitagliptin Phosphate64$61,688
OzempicSemaglutide53$58,862
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$42,105
ProliaDenosumab14$23,692
MyrbetriqMirabegron19$22,503
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$22,488
FarxigaDapagliflozin Propanediol12$18,125
XareltoRivaroxaban15$16,476
MounjaroTirzepatide11$15,212
Hysingla ErHydrocodone Bitartrate11$14,838
Tresiba Flextouch U-100Insulin Degludec14$10,937
Stiolto RespimatTiotropium Br/Olodaterol Hcl13$10,552

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat$169$145,201108 claims
Lilly USA, LLCTrulicity, Mounjaro, Olanzapine$359$106,12686 claims
PfizerEliquis$468$78,97573 claims
GSKTrelegy Ellipta, Anoro Ellipta$148$64,59363 claims
MerckJanuvia$183$61,68864 claims
Novo NordiskOzempic$445$58,86253 claims
AmgenProlia$273$23,69214 claims
Astellas Pharma US IncMyrbetriq$80$22,50319 claims
AstraZenecaFarxiga$198$18,12512 claims
Johnson & JohnsonXarelto$49$16,47615 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$133$9,79011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Canal Winchester

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →